Vorwarts Pharma Expands Its Network of Partners in Central Asia

On April 8–9, one of the key pharmaceutical events of the year in Kazakhstan took place in Almaty — the International Congress and Exhibition “Pharma Kazakhstan and Central Asia 2025.” This event was more than just a platform for industry discussions — it became a true hub for networking and the exchange of innovative ideas. For the first time, Vorwarts Pharma participated in this forum, presenting its initiatives and laying the groundwork for new partnerships across the region.

Key Themes of the Opening Day

The first day began with a plenary session that brought together government representatives, pharmaceutical company leaders, and industry experts to discuss how the public and private sectors can collaborate to develop the pharmaceutical market in line with global trends.

This topic resonates strongly with Vorwarts Pharma — we firmly believe that real change in the industry happens where there is dialogue and trust. It is through partnerships, investments in local manufacturing, and the implementation of advanced technologies that a modern healthcare system can be built — one that is efficient, accessible, and truly centered on people’s needs.

Innovation That Works in Real Life

Throughout the day, speakers discussed topics such as technological modernization of pharmaceutical production, the development of contract manufacturing, and real-time GMP implementation. It was especially insightful to hear practical case studies from companies that have already successfully adopted modern solutions in Kazakhstan.

For our team, these sessions became a valuable space for experience sharing — especially in the area of stick-pack supplement production, which combines convenience, bioavailability, and high quality. We gained valuable insights that we will certainly apply in our future work.

Day Two: Logistics, Quality Control, Technology Transfer

The second day of the Congress focused on optimizing production chains, product labeling, process validation, and quality control. A key highlight was the discussion of how to adapt modern developments to the realities of the Kazakhstani market.

Networking That Matters

Beyond the rich program, the event also offered excellent opportunities for informal communication — helping us to establish new contacts and negotiate promising joint projects across the region.

We see Central Asia as a region with tremendous potential and are committed to contributing to its development. Participation in the International Congress “Pharma Kazakhstan and Central Asia 2025” reaffirmed that open communication and experience sharing are powerful drivers of progress in the pharmaceutical field — unlocking new opportunities for the entire industry.